{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T20:06:59Z","timestamp":1787774819575,"version":"build-2784847793"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T00:00:00Z","timestamp":1763424000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T00:00:00Z","timestamp":1763424000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","award":["R34MH119982"],"award-info":[{"award-number":["R34MH119982"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010409","name":"Children's Investment Fund Foundation","doi-asserted-by":"publisher","award":["1903-03681 and 2106-06589"],"award-info":[{"award-number":["1903-03681 and 2106-06589"]}],"id":[{"id":"10.13039\/100010409","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AIDS Behav"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1007\/s10461-025-04909-2","type":"journal-article","created":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T12:02:33Z","timestamp":1763467353000},"page":"1186-1201","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["A Dual Prevention Pill for HIV & Pregnancy Prevention: A Pilot Study Among Adolescent Girls and Young Women in Zimbabwe"],"prefix":"10.1007","volume":"30","clinical-trial-number":[{"clinical-trial-number":"nct04778514","registry":"10.18810\/clinical-trials-gov"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3085-5259","authenticated-orcid":false,"given":"Nyaradzo M.","family":"Mgodi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Brady","family":"Burnett-Zieman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7032-2318","authenticated-orcid":false,"given":"Caroline","family":"Murombedzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adlight","family":"Dandadzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa","family":"Gatsi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9668-4344","authenticated-orcid":false,"given":"Petina","family":"Musara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheu","family":"Matimbira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gamuchirai","family":"Mavemwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane","family":"Jambaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tinashe","family":"Chidemo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marlena","family":"Plagianos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7631-6760","authenticated-orcid":false,"given":"Lisa B.","family":"Haddad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene V.","family":"Bruce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1645-6734","authenticated-orcid":false,"given":"Sanyukta","family":"Mathur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5041-3634","authenticated-orcid":false,"given":"Barbara A.","family":"Friedland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,18]]},"reference":[{"key":"4909_CR1","unstructured":"Joint United Nations Programme on HIV\/AIDS (UNAIDS). The Urgency of Now: AIDS at a Crossroads \u2014 2024 Global AIDS Update. 2024. Accessed July 29, 2024. https:\/\/www.unaids.org\/sites\/default\/files\/media_asset\/2024-unaids-global-aids-update_en.pdf"},{"key":"4909_CR2","unstructured":"Joint United Nations Programme on HIV\/AIDS (UNAIDS). IN DANGER: UNAIDS Global AIDS Update 2022. 2022. Accessed July 17, 2024. https:\/\/www.unaids.org\/sites\/default\/files\/media_asset\/2022-global-aids-update-summary_en.pdf"},{"key":"4909_CR3","unstructured":"UNAIDS, Country Fact Sheets Z. 2023. Accessed June 7, 2024. https:\/\/www.unaids.org\/en\/regionscountries\/countries\/zimbabwe"},{"issue":"5","key":"4909_CR4","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1056\/NEJMoa1110711","volume":"367","author":"MC Thigpen","year":"2012","unstructured":"Thigpen MC, Kebaabetswe PM, Paxton LA, et al. Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana. N Engl J Med. 2012;367(5):423\u201334.","journal-title":"N Engl J Med"},{"issue":"5","key":"4909_CR5","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1056\/NEJMoa1108524","volume":"367","author":"JM Baeten","year":"2012","unstructured":"Baeten JM, Donnell D, Ndase P, et al. Antiretroviral prophylaxis for HIV prevention in heterosexual men and women. N Engl J Med. 2012;367(5):399\u2013410.","journal-title":"N Engl J Med"},{"key":"4909_CR6","unstructured":"World Health Organization. Global State of PrEP. Global PrEP Network. 2024. Accessed June 6, 2024. https:\/\/www.who.int\/groups\/global-prep-network\/global-state-of-prep"},{"key":"4909_CR7","unstructured":"PrEPWatch; An initiative of AVAC. Data by Country. PrEPWatch. Accessed June 6. 2024. https:\/\/www.prepwatch.org\/data-by-country\/"},{"issue":"7","key":"4909_CR8","doi-asserted-by":"publisher","first-page":"e25962","DOI":"10.1002\/jia2.25962","volume":"25","author":"CL Celum","year":"2022","unstructured":"Celum CL, Bukusi EA, Bekker LG, et al. PrEP use and HIV seroconversion rates in adolescent girls and young women from Kenya and South africa: the POWER demonstration project. J Int AIDS Soc. 2022;25(7):e25962. https:\/\/doi.org\/10.1002\/jia2.25962.","journal-title":"J Int AIDS Soc"},{"key":"4909_CR9","unstructured":"Delany-Moretlwe S, Chersich M, Harvey S, Stangl A, Baron D, Columbini M. Empowerment clubs did not increase PrEP continuation in AGYW in South Africa & Tanzania-results from EMPOWER trial. Presented at: International AIDS Conference.; 2018; Amsterdam."},{"issue":"5","key":"4909_CR10","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1007\/s10461-016-1458-y","volume":"21","author":"KR Amico","year":"2017","unstructured":"Amico KR, Wallace M, Bekker LG, et al. Experiences with HPTN 067\/ADAPT study-provided open-label PrEP among women in cape town: facilitators and barriers within a mutuality framework. AIDS Behav. 2017;21(5):1361\u201375. https:\/\/doi.org\/10.1007\/s10461-016-1458-y.","journal-title":"AIDS Behav"},{"issue":"4","key":"4909_CR11","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1097\/QAI.0000000000000880","volume":"71","author":"A Corneli","year":"2016","unstructured":"Corneli A, Perry B, McKenna K, et al. Participants\u2019 explanations for nonadherence in the FEM-PrEP clinical trial. J Int AIDS Soc. 2016;71(4):452\u201361. https:\/\/doi.org\/10.1097\/QAI.0000000000000880.","journal-title":"J Int AIDS Soc"},{"issue":"2","key":"4909_CR12","doi-asserted-by":"publisher","first-page":"e0246717","DOI":"10.1371\/journal.pone.0246717","volume":"16","author":"N Jani","year":"2021","unstructured":"Jani N, Mathur S, Kahabuka C, Makyao N, Pilgrim N. Relationship dynamics and anticipated stigma: key considerations for PrEP use among Tanzanian adolescent girls and young women and male partners. PLoS ONE. 2021;16(2):e0246717. https:\/\/doi.org\/10.1371\/journal.pone.0246717.","journal-title":"PLoS ONE"},{"issue":"7","key":"4909_CR13","doi-asserted-by":"publisher","first-page":"2190","DOI":"10.1007\/s10461-022-03951-8","volume":"27","author":"BA Friedland","year":"2023","unstructured":"Friedland BA, Plagianos M, Savel C, et al. Women want choices: opinions from the Share.Learn.Shape global internet survey about multipurpose prevention technology (MPT) products in development. AIDS Behav. 2023;27(7):2190\u2013204. https:\/\/doi.org\/10.1007\/s10461-022-03951-8.","journal-title":"AIDS Behav"},{"issue":"3","key":"4909_CR14","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.contraception.2017.10.006","volume":"97","author":"J Hynes","year":"2018","unstructured":"Hynes J, Sales J, Sheth A, Lathrop E, Haddad L. Interest in multipurpose prevention technologies to prevent HIV\/STIs and unintended pregnancy among young women in the united States. Contraception. 2018;97(3):277\u201384. https:\/\/doi.org\/10.1016\/j.contraception.2017.10.006.","journal-title":"Contraception"},{"issue":"3","key":"4909_CR15","doi-asserted-by":"publisher","first-page":"e25094","DOI":"10.1002\/jia2.25094","volume":"21","author":"A van der Straten","year":"2018","unstructured":"van der Straten A, Agot K, Ahmed K, et al. The Tablets, Ring, injections as options (TRIO) study: what young African women chose and used for future HIV and pregnancy prevention. J Int AIDS Soc. 2018;21(3):e25094. https:\/\/doi.org\/10.1002\/jia2.25094.","journal-title":"J Int AIDS Soc"},{"issue":"1","key":"4909_CR16","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1007\/s10461-017-1913-4","volume":"22","author":"M Beksinska","year":"2018","unstructured":"Beksinska M, Greener R, Smit J, et al. A randomized crossover study evaluating the use and acceptability of the SILCS diaphragm compared to vaginal applicators for vaginal gel delivery. AIDS Behav. 2018;22(1):127\u201332. https:\/\/doi.org\/10.1007\/s10461-017-1913-4.","journal-title":"AIDS Behav"},{"issue":"Suppl 5","key":"4909_CR17","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1111\/1471-0528.12842","volume":"121","author":"S Karim","year":"2014","unstructured":"Karim S, Baxter C, Frohlich J, Karim Q. The need for multipurpose prevention technologies in sub-Saharan Africa. BJOG. 2014;121(Suppl 5):27\u201334.","journal-title":"BJOG"},{"issue":"4","key":"4909_CR18","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1111\/sifp.12178","volume":"52","author":"LE Miller","year":"2021","unstructured":"Miller LE, Zamudio-Haas S, Otieno B, et al. We don\u2019t fear HIV. We just fear walking around Pregnant.: A qualitative analysis of adolescent sexuality and pregnancy stigma in informal settlements in Kisumu, Kenya. Stud Fam Plann. 2021;52(4):557\u201370. https:\/\/doi.org\/10.1111\/sifp.12178.","journal-title":"Stud Fam Plann"},{"issue":"1","key":"4909_CR19","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1186\/s12884-023-05802-3","volume":"23","author":"AK Daniel","year":"2023","unstructured":"Daniel AK, Casmir E, Oluoch L, et al. I was just concerned about getting pregnant: attitudes toward pregnancy and contraceptive use among adolescent girls and young women in Thika, Kenya. BMC Pregnancy Childbirth. 2023;23(1):493. https:\/\/doi.org\/10.1186\/s12884-023-05802-3.","journal-title":"BMC Pregnancy Childbirth"},{"key":"4909_CR20","unstructured":"The IMPT. MPT Product Development Database. September 2023. Accessed June 6, 2024. https:\/\/mpts101.org\/"},{"issue":"8","key":"4909_CR21","doi-asserted-by":"publisher","first-page":"e26346","DOI":"10.1002\/jia2.26346","volume":"27","author":"C Verde Hashim","year":"2024","unstructured":"Verde Hashim C, Llewellyn E, Wood R, et al. Harnessing private sector strategies for family planning to deliver the dual prevention Pill, the first multipurpose prevention technology with pre-exposure prophylaxis, in an expanding HIV prevention landscape. J Int AIDS Soc. 2024;27(8):e26346. https:\/\/doi.org\/10.1002\/jia2.26346.","journal-title":"J Int AIDS Soc"},{"key":"4909_CR22","unstructured":"United Nations Department of Economic and Social Affairs. Contraceptive Use by Method 2019. United Nations: Department of Economic and Social Affairs. 2019. https:\/\/www.un.org\/development\/desa\/pd\/sites\/www.un.org.development.desa.pd\/files\/files\/documents\/2020\/Jan\/un_2019_contraceptiveusebymethod_databooklet.pdf"},{"key":"4909_CR23","unstructured":"Zimbabwe. The DHS STATcompiler. 2015. Accessed December 8, 2023. https:\/\/www.statcompiler.com\/en\/"},{"issue":"3","key":"4909_CR24","doi-asserted-by":"publisher","first-page":"e075381","DOI":"10.1136\/bmjopen-2023-075381","volume":"14","author":"BA Friedland","year":"2024","unstructured":"Friedland BA, Mgodi NM, Palanee-Phillips T, et al. Assessing the acceptability of, adherence to and preference for a dual prevention pill (DPP) for HIV and pregnancy prevention compared to oral pre-exposure prophylaxis (PrEP) and oral contraception taken separately: protocols for two randomised, controlled, cross-over studies in South Africa and Zimbabwe. BMJ Open. 2024;14(3):e075381. https:\/\/doi.org\/10.1136\/bmjopen-2023-075381.","journal-title":"BMJ Open"},{"key":"4909_CR25","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.jpba.2013.08.033","volume":"88","author":"JH Zheng","year":"2014","unstructured":"Zheng JH, Guida LA, Rower C, et al. Quantitation of Tenofovir and emtricitabine in dried blood spots (DBS) with LC-MS\/MS. J Pharm Biomed Anal. 2014;88:144\u201351. https:\/\/doi.org\/10.1016\/j.jpba.2013.08.033.","journal-title":"J Pharm Biomed Anal"},{"key":"4909_CR26","unstructured":"US Department of Health and Human Services, National Institutes of Health, National Institute of Allergy and Infectious Diseases, Division of AIDS. Division of AIDS (DAIDS) Table for Grading the Severity of Adult and Pediatric Adverse Events. Corrected Version 2.1. 2017. Accessed February 27, 2023. https:\/\/rsc.niaid.nih.gov\/sites\/default\/files\/daidsgradingcorrectedv21.pdf"},{"issue":"14","key":"4909_CR27","doi-asserted-by":"publisher","first-page":"405","DOI":"10.15585\/mmwr.mm6914a3","volume":"69","author":"NK Tepper","year":"2020","unstructured":"Tepper NK, Curtis KM, Cox S, Whiteman MK. Update to US medical eligibility criteria for contraceptive use, 2016: updated recommendations for the use of contraception among women at high risk for HIV infection. Morb Mortal Wkly Rep. 2020;69(14):405.","journal-title":"Morb Mortal Wkly Rep"},{"issue":"24","key":"4909_CR28","doi-asserted-by":"publisher","first-page":"2507","DOI":"10.1001\/jama.2021.21392","volume":"326","author":"S Teal","year":"2021","unstructured":"Teal S, Edelman A. Contraception Selection, Effectiveness, and adverse effects: A review. JAMA. 2021;326(24):2507\u201318. https:\/\/doi.org\/10.1001\/jama.2021.21392.","journal-title":"JAMA"},{"issue":"6","key":"4909_CR29","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1097\/QAD.0000000000003500","volume":"37","author":"A Rao","year":"2023","unstructured":"Rao A, Lesko C, Mhlophe H, et al. Longitudinal patterns of initiation, persistence, and cycling on preexposure prophylaxis among female sex workers and adolescent girls and young women in South Africa. AIDS Lond Engl. 2023;37(6):977\u201386. https:\/\/doi.org\/10.1097\/QAD.0000000000003500.","journal-title":"AIDS Lond Engl"},{"key":"4909_CR30","doi-asserted-by":"publisher","first-page":"1048702","DOI":"10.3389\/frph.2022.1048702","volume":"4","author":"G Barnabee","year":"2022","unstructured":"Barnabee G, O\u2019Bryan G, Ndeikemona L, et al. Improving HIV pre-exposure prophylaxis persistence among adolescent girls and young women: insights from a mixed-methods evaluation of community, hybrid, and facility service delivery models in Namibia. Front Reprod Health. 2022;4:1048702. https:\/\/doi.org\/10.3389\/frph.2022.1048702.","journal-title":"Front Reprod Health"},{"key":"4909_CR31","doi-asserted-by":"publisher","unstructured":"Bhushan NL, Ridgeway K, Luecke EH, Palanee-Phillips T, Montgomery ET, Minnis AM. Synthesis of End-User research to inform future multipurpose prevention technologies in Sub-Saharan africa: A scoping review. Front Reproductive Health. 2023;5. https:\/\/doi.org\/10.3389\/frph.2023.1156864.","DOI":"10.3389\/frph.2023.1156864"},{"issue":"5","key":"4909_CR32","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1056\/NEJMoa1202614","volume":"367","author":"L Van Damme","year":"2012","unstructured":"Van Damme L, Corneli A, Ahmed K, et al. Preexposure prophylaxis for HIV infection among African women. New Eng J Med. 2012;367(5):411\u201322. https:\/\/doi.org\/10.1056\/NEJMoa1202614.","journal-title":"New Eng J Med"},{"issue":"6","key":"4909_CR33","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1056\/NEJMoa1402269","volume":"372","author":"J Marrazzo","year":"2015","unstructured":"Marrazzo J, Ramjee G, Richardson B, et al. Tenofovir-based preexposure prophylaxis for HIV infection among African women. N Engl J Med. 2015;372(6):509\u201318.","journal-title":"N Engl J Med"},{"issue":"3","key":"4909_CR34","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1002\/ejsp.2420150303","volume":"15","author":"AJ Nederhof","year":"1985","unstructured":"Nederhof AJ. Methods of coping with social desirability bias: A review. Eur J Soc Psychol. 1985;15(3):263\u201380. https:\/\/doi.org\/10.1002\/ejsp.2420150303.","journal-title":"Eur J Soc Psychol"},{"issue":"7","key":"4909_CR35","doi-asserted-by":"publisher","first-page":"F13","DOI":"10.1097\/QAD.0b013e3283522272","volume":"26","author":"A van der Straten","year":"2012","unstructured":"van der Straten A, Van Damme L, Haberer JE, Bangsberg DR. Unraveling the divergent results of pre-exposure prophylaxis trials for HIV prevention. AIDS Lond Engl. 2012;26(7):F13\u201319. https:\/\/doi.org\/10.1097\/QAD.0b013e3283522272.","journal-title":"AIDS Lond Engl"},{"issue":"9","key":"4909_CR36","doi-asserted-by":"publisher","first-page":"595","DOI":"10.2165\/00003088-200443090-00003","volume":"43","author":"BP Kearney","year":"2004","unstructured":"Kearney BP, Flaherty JF, Shah J. Tenofovir disoproxil fumarate: clinical Pharmacology and pharmacokinetics. Clin Pharmacokinet. 2004;43(9):595\u2013612. https:\/\/doi.org\/10.2165\/00003088-200443090-00003.","journal-title":"Clin Pharmacokinet"},{"issue":"7","key":"4909_CR37","doi-asserted-by":"publisher","first-page":"ofad360","DOI":"10.1093\/ofid\/ofad360","volume":"10","author":"ML Hirsh","year":"2023","unstructured":"Hirsh ML, Edwards JA, Robichaux C, et al. Food insecurity is associated with low Tenofovir diphosphate in dried blood spots in South African persons with HIV. Open Forum Infect Dis. 2023;10(7):ofad360. https:\/\/doi.org\/10.1093\/ofid\/ofad360.","journal-title":"Open Forum Infect Dis"},{"issue":"1","key":"4909_CR38","doi-asserted-by":"publisher","first-page":"e0227632","DOI":"10.1371\/journal.pone.0227632","volume":"15","author":"MM Gombe","year":"2020","unstructured":"Gombe MM, Cakouros BE, Ncube G, et al. Key barriers and enablers associated with uptake and continuation of oral pre-exposure prophylaxis (PrEP) in the public sector in zimbabwe: qualitative perspectives of general population clients at high risk for HIV. PLoS ONE. 2020;15(1):e0227632.","journal-title":"PLoS ONE"},{"issue":"2","key":"4909_CR39","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1007\/s10865-023-00462-2","volume":"47","author":"E Krogstad Mudzingwa","year":"2024","unstructured":"Krogstad Mudzingwa E, de Vos L, Atujuna M, et al. High study participation but diverging adherence levels: qualitatively unpacking PrEP use among adolescent girls and young women over two years in Eastern Cape, South Africa. J Behav Med. 2024;47(2):320\u201333. https:\/\/doi.org\/10.1007\/s10865-023-00462-2.","journal-title":"J Behav Med"},{"key":"4909_CR40","unstructured":"The DPP Consortium. Frequently Asked Questions about the Dual Prevention Pill. Published online August 2021. Accessed February 27. 2023. https:\/\/www.prepwatch.org\/wp-content\/uploads\/2021\/09\/FAQS-about-the-DPP.pdf"}],"container-title":["AIDS and Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10461-025-04909-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10461-025-04909-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10461-025-04909-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T08:08:20Z","timestamp":1776067700000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10461-025-04909-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,18]]},"references-count":40,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["4909"],"URL":"https:\/\/doi.org\/10.1007\/s10461-025-04909-2","relation":{},"ISSN":["1090-7165","1573-3254"],"issn-type":[{"value":"1090-7165","type":"print"},{"value":"1573-3254","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,18]]},"assertion":[{"value":"13 September 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors have no competing interests to declare that are relevant to the content of this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}},{"value":"The study was sponsored by the Population Council (ClinicalTrials.gov Identifier NCT04778514). The protocol (PC #952) was reviewed and approved by the Population Council\u2019s Institutional Review Board (New York, NY, USA), the Zimbabwe Ministry of Health and Child Care, Medical Research Council of Zimbabwe (REF MRCZ\/A\/2576), Medicines Control Authority of Zimbabwe, Research Council of Zimbabwe, Chitungwiza City Health Ethics Committee; and the Joint Research Ethics Committee for the University of Zimbabwe\u202fFaculty of Medicine\u202fand\u202fHealth Sciences and Parirenyatwa Group of Hospitals. Each participant provided written informed consent in Shona before undergoing any study procedures.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}